You are here: Industry Insights > Recovery

News List

Antibody cocktail improves survival in seronegative hospitalised COVID-19 patients europeanpharmaceuticalreview
June 18, 2021
Phase III data shows REGEN-COV™ (casirivimab and imdevimab) reduced risk of death by 20 percent in hospitalised COVID-19 patients lacking an immune response to SARS-CoV-2.
REGEN-COV Phase 3 Trial Meets Primary Outcome contractpharma
June 17, 2021
Improves survival by 20% in hospitalized COVID-19 patients lacking an immune response to SARS-CoV-2.
No survival benefit from aspirin in COVID-19 patients pharmatimes
June 10, 2021
Findings of the UK RECOVERY trial show that use of aspirin in the hope of reducing blood clotting in patients hospitalised with COVID-19 does not have any impact on survival.
Colchicine added to UK’s COVID-19 ‘RECOVERY’ trial pharmatimes
December 01, 2020
Commonly used anti-inflammatory drug colchicine is set to be investigated in the UK’s RECOVERY trial, which is testing treatments for patients hospitalised with COVID-19.
UK study will evaluate aspirin as a potential COVID-19 treatment pharmatimes
November 11, 2020
Researchers from the UK’s RECOVERY study will evaluate the standard painkiller aspirin as a potential treatment for COVID-19 patients.
Trial in Britain to assess aspirin as potential COVID-19 drug expresspharma
November 09, 2020
The scientists behind the RECOVERY trial, which is looking into a range of potential treatments for COVID-19, said it would include the drug, which is commonly used as a blood thinner.
CMOs urge trusts to continue recruiting for RECOVERY trial pharmatimes
August 21, 2020
The UK’s four Chief Medical Officers (CMOs) and NHS England and Improvements’ National Medical Director are urging NHS trusts across the country to continue recruiting high numbers of COVID-19 patients into the RECOVERY trial.
Japan approves dexamethasone to treat Covid-19 patients pharmaceutical-technology
July 23, 2020
The Japanese health ministry has approved a low-cost and widely available steroid drug, dexamethasone, for the treatment of patients suffering from Covid-19.
Dexamethasone added to COVID-19 treatment protocol expresspharma
June 28, 2020
The Union Ministry of Health & Family Welfare released an updated clinical management protocol for managing COVID-19 cases which advises the use of Dexamethasone as an alternative choice to Methylprednisolone to manage moderate to severe cases of COVID-19
Nearly 60 pct of imported COVID-19 cases discharged from hospital after recovery: official chinadaily
April 27, 2020
Nearly 60 percent of imported COVID-19 cases on the Chinese mainland had been cured and discharged from hospital as of April 25, a health official said on April 26.

Previous page 1 2 Next page